Physician profile
Samuel E Smith
NPI 1285662528
$3,240.41
in general payments reported to CMS, 2019-2025
10 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $318 · 2021: $274 · 2022: $229 · 2023: $817 · 2024: $299 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,500.30 | 2021-2025 | Mazor X System, Osteocool Rf Ablation System, Unid_pass |
| Seaspine Orthopedics Corporation | $831.53 | 2019 | |
| Medtronic USA, INC. | $402.33 | 2019-2020 | |
| Depuy Synthes Sales INC. | $202.54 | 2019-2023 | Viper |
| Orthofix Medical, INC. | $116.51 | 2024 | Mariner |
| Stryker Corporation | $52.27 | 2019 | |
| Alphatec Spine, INC | $45.49 | 2022 | |
| Augmedics INC. | $44.41 | 2023 | Xvision |
| Cerapedics INC. | $23.87 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $21.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.